Publications
5900 Results
- Journal / Conference
- Trials. 2026 Aug 27;27(1):550. doi: 10.1186/s13063-026-09969-w
- Year
- 2026
- Research Committee(s)
- Myeloma
- PMID
- 42661196
- PMC
- PMC13520253
- Study Number(s)
- S0777
Interim analysis in clinical trials: caution against premature conclusions—the SWOG multiple myeloma S0777 case study
- Journal / Conference
- JCO Oncol Adv . 2026 Jan;3(1):e2500143. doi: 10.1200/oa-25-00143. Epub 2026 Feb 26.
- Year
- 2026
- Research Committee(s)
- Lymphoma
- PMID
- 42577949
- PMC
- PMC13456540
- Study Number(s)
- S1826
Nivolumab + Doxorubicin, Vinblastine, and Dacarbazine in HIV-Associated Advanced-Stage Classic Hodgkin Lymphoma
- Journal / Conference
- JCO Oncology Practice 2026
- Year
- 2026
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S1415CD
Impact of Primary Prophylactic Colony-Stimulating Factor Delivery Method on Febrile Neutropenia: Secondary Analysis of a Pragmatic Cluster Randomized Clinical Trial
- Journal / Conference
- WCLC 2026
- Year
- 2026
- Research Committee(s)
- Lung
- Study Number(s)
- S2302
Simplified Trials, Broader Reach: Lessons from SWOG S2302 Pragmatica-Lung
- Journal / Conference
- The Lancet
- Year
- 2026
- Research Committee(s)
- Lung
- Study Number(s)
- S1914
Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial
- Journal / Conference
- Population Health Management (Popul Health Manag) 2025 Dec;28(6):313-321. doi: 10.1089/pop.2022.0143. Epub 2023 Jan 10.
- Year
- 2025
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID36625863
- PMC
- 13014128
- Study Number(s)
- S0000
Racial and Ethnic Disparity in Preference-Weighted Quality of Life: Findings from the Selenium and Vitamin E Cancer Prevention Trial
- Journal / Conference
- Cancer 2025 Jan 1;131(1):e35587. doi: 10.1002/cncr.35587. Epub 2024 Sep 29.
- Year
- 2025
- Research Committee(s)
- Melanoma
- PMID
- PMID39342463
- PMC
- PMC11694162
- Study Number(s)
- S0826
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma
- Journal / Conference
- Blood Jan 2;145(1):75-84
- Year
- 2025
- Research Committee(s)
- Myeloma
- PMID
- PMID39321347
- Study Number(s)
- S0777, S1211
Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis
- Journal / Conference
- Breast Cancer Research and Treatment Feb;209(3):603-611
- Year
- 2025
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- PMID39560823
- Study Number(s)
- S0927, S1200, S1202
Neighborhood socioeconomic deprivation and patient-reported outcomes in symptom management trials for women with breast cancer
- Journal / Conference
- Cancer Jan 1;131(1):e35560
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39283236
- PMC
- PMC11834169